SYNTHETIC BIOLOGICS INC's ticker is SYN and the CUSIP is 87164U102. A total of 31 filers reported holding SYNTHETIC BIOLOGICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,000 | 0.0% | 1,813 | +74.5% | 0.00% | – |
| Q3 2017 | $1,000 | -92.3% | 1,039 | -95.4% | 0.00% | -100.0% |
| Q2 2017 | $13,000 | -82.9% | 22,801 | -81.2% | 0.00% | -87.5% |
| Q1 2017 | $76,000 | +1166.7% | 121,100 | +1517.5% | 0.01% | +700.0% |
| Q4 2016 | $6,000 | – | 7,487 | +2824.6% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 256 | -15.8% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 304 | -40.4% | 0.00% | – |
| Q4 2015 | $1,000 | -85.7% | 510 | -83.0% | 0.00% | -100.0% |
| Q3 2015 | $7,000 | -22.2% | 3,001 | -2.0% | 0.00% | 0.0% |
| Q2 2015 | $9,000 | +200.0% | 3,062 | +103.9% | 0.00% | – |
| Q1 2015 | $3,000 | 0.0% | 1,502 | -30.3% | 0.00% | – |
| Q4 2014 | $3,000 | -25.0% | 2,156 | -8.3% | 0.00% | – |
| Q3 2014 | $4,000 | +300.0% | 2,350 | +305.9% | 0.00% | – |
| Q2 2014 | $1,000 | -75.0% | 579 | -61.9% | 0.00% | -100.0% |
| Q1 2014 | $4,000 | – | 1,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 13,238,268 | $6,726,000 | 0.58% |
| MSD Partners, L.P. | 4,118,402 | $2,092,000 | 0.11% |
| 683 Capital Management, LLC | 1,500,000 | $762,000 | 0.06% |
| Vivaldi Capital Management LP | 101,145 | $51,000 | 0.04% |
| Alyeska Investment Group, L.P. | 5,000,000 | $2,540,000 | 0.02% |
| BARD ASSOCIATES INC | 56,499 | $29,000 | 0.01% |
| FRANKLIN STREET ADVISORS INC /NC | 126,000 | $64,000 | 0.01% |
| Virtu Financial LLC | 299,577 | $152,000 | 0.01% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 46,981 | $24,000 | 0.01% |
| Stanley-Laman Group, Ltd. | 60,323 | $31,000 | 0.01% |